Protection against MIS-C outweighs the risk of myocarditis after Covid-19 vaccination in children.

Journal: Italian Journal Of Pediatrics

Published: January 26, 2022

Abstract

From March 2020 to July 2022, in Liguria region (North-West Italy) incidence of MIS-C among pediatric patients infected by SARS-CoV-2 was 38.7/100.000, which is higher than that of myocarditis after COVID-19 vaccination. In our opinion severity of MIS-C-related cardiac disease outweigh the risk of myocarditis after COVID-19 vaccine.

Authors

Marcello Mariani, Roberta Caorsi, Alessandro Consolaro, Giacomo Brisca, Camilla Sticchi, Marco Gattorno, Elio Castagnola, Angelo Ravelli

Relevant Conditions

Severe Acute Respiratory Syndrome (SARS), Cardiomyopathy, Multisystem Inflammatory Syndrome in Children (MIS-C), Pediatric Myocarditis, COVID-19, Myocarditis

Similar Publications

View All